FGP — on-the-record assessments

Peptide content was declared and the declared figure sat within method repeatability of the independent determination. The assessor has placed subsequent orders with the same supplier.

Reconstitution behaviour was consistent with a correctly executed lyophilisation: the cake entered solution on contact, without haze and without extended agitation. No excipient was present and the lyophilised cake was intact. Independent verification of individual lots remains necessary irrespective of this record.

Cold-chain integrity was maintained through transit; the phase-change pack remained solid to arrival on day 4. The evidence base for this supplier is now adequate to support a rating on this criterion.

Purity was reported with the chromatographic method named, so the figure can be read against the conditions that produced it. Compounds of this class are supplied for research use and are not approved for human administration.

Documentation was complete at first issue. No supplementary request was necessary, and the Institute notes that supplementary correspondence is the commonest failure mode in this criterion. The gradient and column chemistry are stated, permitting the determination to be reproduced. Nothing in this submission constitutes medical advice.

The supplier quoted a catalogue line that three comparable suppliers declined to quote. Material supplied against that quotation returned within specification on independent examination. Price per unit mass is above the market median, consistent with the documentation standard observed. The assessor has placed subsequent orders with the same supplier.

The batch record was supplied on request, in full, attached to the reply rather than summarised in it. The assessor declares no interest in the supplier beyond the transactions described.

Storage conditions on the certificate were written for the compound rather than reproduced from a catalogue template. No excipient was present and the lyophilised cake was intact. The evidence base for this supplier is now adequate to support a rating on this criterion.

The certificate accompanying this consignment satisfies the Institute’s minimum data standard: it carries water content by Karl Fischer in addition to the critical fields. The reorder placed at 9 months returned a figure within one tenth of a point of the original. Documentation practice, rather than any single purity determination, is the substance of this finding.

A repeat determination on the same catalogue line at 9 months returned 98.3%, against 98.3% originally. No evidence of process drift is present in this sample. Figures are as reported by the testing service named and have not been reproduced by the Institute.

Material from lot FGP-25-248 was submitted to VendorInvestigate; the determination returned 99.4% against a declared 99.0%, a difference within the stated repeatability of the method.

Documentation for the lot was complete at first issue and required no supplementary request. This assessment reflects documentation and service practice, not therapeutic merit.

This assessor has placed 10 orders across 12 months and holds documentation for each. The set is internally consistent. A signature and release date appear on the certificate.

Water content is reported by Karl Fischer titration with the determination method named, which the rubric requires and which a minority of suppliers provide. The PeptideMeter report is held on file and corresponds to the figures published by the supplier. Nothing in this submission constitutes medical advice.

Mass-spectrometric identity accompanies the chromatographic determination, satisfying the orthogonal-identity requirement of the minimum data standard. The reorder placed at 10 months returned a figure within one tenth of a point of the original. Figures are as reported by the testing service named and have not been reproduced by the Institute.

A supplementary certificate covering a lot released 18 months previously was produced from the supplier’s records on request, indicating that release records are retained rather than reconstructed. Peptide content was declared at 98.0%.

The storage condition against which the stability statement was written is stated on the certificate, which permits the statement to be evaluated rather than merely noted. The gradient and column chemistry are stated, permitting the determination to be reproduced. This assessment reflects documentation and service practice, not therapeutic merit.

Material obtained directly from the manufacturer returned 98.8%; material of nominally identical description obtained through an intermediary returned 98.8%. The comparison is offered without further comment. Catalogue availability corresponded to the published catalogue.

Delivery was completed on day 3 against a quoted 3 days from stock held in Australia. Customs documentation was correct at first presentation. A signature and release date appear on the certificate.

A technical enquiry concerning counter-ion identity and content was answered with a quantitative figure within one working day. Responses of this character are recorded because they are uncommon. The submission is recorded in full in the evidence log.

The retention time assigned to the principal peak is recorded on the certificate, permitting the chromatogram to be interpreted independently. Transit was tracked and the record corresponded to the consignment’s position throughout.

The declared figure was not adjusted upward between the certificate and the commercial documentation. Discrepancies of this kind are specifically screened for. The supplementary certificate was retrieved without demur. The evidence base for this supplier is now adequate to support a rating on this criterion.

Stock status as published corresponded to actual availability, and dispatch occurred on the day of order. The gradient and column chemistry are stated, permitting the determination to be reproduced. Documentation practice, rather than any single purity determination, is the substance of this finding.

Across 15 months and 12 orders no substitution, reformulation or post-payment unavailability was encountered by this assessor.

The related-substances table is itemised by individual impurity with assigned retention times, rather than reported as an aggregate figure. A signature and release date appear on the certificate.

Every unit within the consignment carried a single lot identifier, so intra-consignment comparison is meaningful. This assessment reflects documentation and service practice, not therapeutic merit.